Literature DB >> 10531288

Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.

E Konadu1, A Donohue-Rolfe, S B Calderwood, V Pozsgay, J Shiloach, J B Robbins, S C Szu.   

Abstract

Escherichia coli O157 is the major cause of diarrhea-associated hemolytic uremic syndrome (HUS). Strains causing HUS contain either Shiga toxin 1 (Stx1) or Stx2, or both. In adult volunteers, conjugate vaccines of detoxified lipopolysaccharide (LPS) elicited bactericidal antibodies to E. coli O157. Here, the detoxified LPS was conjugated with improved schemes to the nontoxic B subunit of Stx1. Mice injected with these bivalent conjugates elicited both bactericidal antibodies to E. coli O157 and neutralization antibodies to Stx1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531288      PMCID: PMC97014     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.

Authors:  B P Bell; P M Griffin; P Lozano; D L Christie; J M Kobayashi; P I Tarr
Journal:  Pediatrics       Date:  1997-07       Impact factor: 7.124

2.  In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.

Authors:  D L Weinstein; M P Jackson; L P Perera; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Hemolytic-uremic syndrome associated with a variant Shiga-like cytotoxin of Escherichia coli O111.

Authors:  M Bitzan; H Karch; H Altrogge; J Strehlau; F Bläker
Journal:  Pediatr Infect Dis J       Date:  1988-02       Impact factor: 2.129

4.  Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2.

Authors:  S M Scotland; G A Willshaw; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

5.  Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi.

Authors:  S C Szu; X R Li; R Schneerson; J H Vickers; D Bryla; J B Robbins
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  The structure of the antigenic lipopolysaccharide O-chains produced by Salmonella urbana and Salmonella godesberg.

Authors:  M B Perry; D R Bundle; L MacLean; J A Perry; D W Griffith
Journal:  Carbohydr Res       Date:  1986-11-15       Impact factor: 2.104

7.  Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.

Authors:  M A Neill; P I Tarr; C R Clausen; D L Christie; R O Hickman
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

8.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  12 in total

1.  Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.

Authors:  Satoshi Ishikawa; Kazuyoshi Kawahara; Yutaka Kagami; Yasunori Isshiki; Aki Kaneko; Hidenori Matsui; Nobuhiko Okada; Hirofumi Danbara
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia.

Authors:  Paola Marcato; Thomas P Griener; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.

Authors:  Robert L G Rojas; Priscila A D P Gomes; Leticia V Bentancor; Maria E Sbrogio-Almeida; Sérgio O P Costa; Liliana M Massis; Rita C C Ferreira; Marina S Palermo; Luís C S Ferreira
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

4.  Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.

Authors:  X Shen; T Lagergård; Y Yang; M Lindblad; M Fredriksson; J Holmgren
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.

Authors:  Leticia V Bentancor; Marcos Bilen; Romina J Fernández Brando; María Victoria Ramos; Luis C S Ferreira; Pablo D Ghiringhelli; Marina S Palermo
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

Review 6.  Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.

Authors:  Victor A Garcia-Angulo; Anjana Kalita; Alfredo G Torres
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

7.  ATF3 plays a key role in Kdo2-lipid A-induced TLR4-dependent gene expression via NF-κB activation.

Authors:  Eun-Young Kim; Hye Young Shin; Joo-Young Kim; Dong-Gun Kim; Yong-Min Choi; Hyuk-Kwon Kwon; Dong-Kwon Rhee; You-Sun Kim; Sangdun Choi
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

8.  Glycoconjugate vaccine containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein elicits humoral and cellular responses.

Authors:  Zhongrui Ma; Huajie Zhang; Wenjing Shang; Faliang Zhu; Weiqing Han; Xueer Zhao; Donglei Han; Peng George Wang; Min Chen
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

9.  Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine.

Authors:  Shadi Rokhsartalab-Azar; Reza Shapouri; Mehdi Rahnema; Faezeh Najafzadeh; Anvarsadat Kianmehr
Journal:  Iran J Microbiol       Date:  2015-06

10.  Purification and antigenic detection of O-specific polysaccharides of Salmonella enterica serovar Paratyphi A isolate from Pakistan: an emerging threat.

Authors:  Zainab Rahmat; Aamir Ali; Yasra Sarwar; Muhammad Salman; Abdul Haque
Journal:  Springerplus       Date:  2016-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.